Several derivatives of benzimidazole were tested for antiviral activity; of these the I-fl-D-2'-deoxyriboside of 5,6-dichlorobenzimidazole and the and fl anomers of 5,6-dimethyl-I-(2'-deoxy-D-ribofuranosyl)benzimidazole inhibited the reproduction in vitro of two DNA viruses, herpes simplex virus and polyoma virus; 5,6-dichloro-I-(2'-deoxy-fl-D-ribofuranosyl)benzimidazole (dDBZ) was the most inhibitory compound. Pretreatment of the host cells with dDBZ, subsequently removed by washing, did not affect the yield of these viruses, dDBZ did not have any direct inactivation effect on herpes simplex virus. Growth curves of herpes virus in the presence of dDBZ indicated that a reduced yield of the virus was obtained after a considerable lag, the first progeny virus being detected 24 hr after infection. Marked inhibition could be demonstrated when the compound was added as late as 15 hr after infection. Attempts to prevent the inhibition by dDBZ by addition of the following compounds failed: deoxyadenosine, deoxyguanosine, deoxycytidine, thymidine, adenine and adenosine. 5,6-Dichlorobenzimidazole, its ribonucleoside (5,6-dichloro-I-(/?-D-ribofuranosyl)benzimidazole (DRB)) and the corresponding deoxyribonucleoside (dDBZ) were compared for their relative antiviral activity against a DNA virus (herpes simplex virus) and RNA viruses (three strains of polio virus). All three compounds inhibited herpes simplex virus; the 5,6-dichlorobenzimidazole inhibited two strains of polio virus; and DRB inhibited all three strains of polio virus, dDBZ had the least inhibitory activity for two of the three strains of polio virus and did not inhibit the LSC I 2AB strain of polio virus, dDBZ at a concentration required to inhibit viral replication inhibited the synthesis of RNA and to a lesser extent that of DNA and protein of uninfected green monkey kidney cells.
INTRODUCTION
The antiviral activity of benzimidazole was first described by Thompson (I947) and Thompson et al. (195o) and that of certain I-(/LD-ribofuranosyl) benzimidazoles was reported by Tamm (I956a, b) and by co-workers (1954, 1957a, b) . The ability of adenosine to reverse the inhibition of influenza B virus by 5,6-dichloro-I-(fl-D-ribofuranosyl) benzimidazole (DRB) (Tamm, Nemes & Osterhout, 196o ) and the studies of others (Allfrey, Mirsky & Osawa, 1957; Sirlin & Jacob, 1964; Tamm, I956a) indicated a prime inhibitory effect on the synthesis of RNA. Tamm et al. (196o) observed that the concentration of DRB required to prevent viral reproduction inhibited the utilization of [a~C] adenosine for the biosynthesis of RNA of uninfected chick chorioallantoic membrane. Thus the antiviral effect of DRB may be secondary to an effect on the host cells.
The desirability of studying the potential antiviral activity of 2'-deoxy-D-ribofuranosyl benzimidazoles was expressed by Cooley et al. (195o) and by Tamm (I956a) . The synthesis of these derivatives was accomplished by Whittle & Robins (I 965) , and the present report describes the antiviral activity, cytotoxicity and biochemical effects of several of these compounds.
METHODS
Cells. The stable cell line of green monkey kidney cells BSCI (Hopps et al. I963) was used for the growth and assay of herpes simplex virus and for the growth of poliovirus strains. Primary rhesus monkey kidney cells were used for the assay of polioviruses. Primary baby mouse kidney cells were used for the growth of polyoma virus, and secondary mouse embryo cells were used for its assay.
Media. All cells were grown and maintained in Eagle's basal medium (BME) with lO ~o foetal calf serum, IOO units of penicillin per ml., IOO/*g. of streptomycin per ml., and 2"5/zg. of Fungizone (Squibb) per ml.
Viruses. Herpes simplex virus (ROLLY strain I 0 was obtained from Dr J. W. Cramer (Yale University); polyoma virus was obtained from Dr R. Well (Swiss Cancer Institute, Lausanne, Switzerland); and the strains of poliovirus were obtained from Dr F. L. Black (Yale University).
Compounds. Benzimidazole derivatives were synthesized as described previously (Whittle & Robins, I965) . The structures of some of these compounds are shown in Fig. I . The 5,6-positions of the benzimidazole ring are substituted either by chlorine or methyl groups, and the pentose moiety is either in the c¢ or/? configuration. The compounds were dissolved to maximal attainable solubility in distilled water, sterilized by filtration through a Nalgene filter of o'45 nm. porosity, and frozen until used, when they were diluted in the medium described above. The compounds used in the reversal studies were treated in a similar manner.
Infectivity assays. Herpes simplex virus was assayed by the macroplaque technique using o'4 ~o human 7-globulin (Roizman & Roane, 196 I) . Macroplaques were counted 4 or 5 days after infection. Polyoma virus was assayed by the plaque technique using secondary mouse embryo cells grown in 6o mm. plastic Petri dishes (Dulbecco & Freeman, 1959) . The overlay medium (2to ml.) consisted of the following ingredients: agar 1-8 g. ; BME (2 ×, without phenol red) 8o ml.; foetal calf serum, 40 ml.; distilled water, 8o ml. ; penicillin, 2o,ooo units; streptomycin, 2o mg. and Fungizone, 500/zg. Eight ml. of this overlay were used per Petri dish and on the Ioth day 4 ml. of a solution of neutral red at a concentration of I/IO,OOO were added. Cultures were incubated overnight at 37 ° , the solution of neutral red removed and the plaques counted between I I and I4 days after infection. The overlay medium used in the plaque assay for polio virus was that described by Hsiung & Melnick (1955) but with a supplementation of 0"4% NaHCO8 and 25 mM of MgCI~ (Wallis, Melnick & Bianchi, 1962 ) . Plaques were counted on the 3rd and 4th day. Virus dilutions were plated at o'5 log intervals in order to get accurate plaque counts.
Cytoxieity studies. Compounds were diluted as described above, and I ml. of these dilutions was included in each tube of cells. The control tube contained I ml. of medium only. Four to 6 tubes were used per dilution of the compound. Cells were observed microscopically daily for 7 to io days and graded arbitrarily for cytoxicity. virus per cell. The viruses were allowed to adsorb for I hr at 37 °. The cells were washed twice to remove unadsorbed virus before addition of the solution of the test compound to the culture. Normal maintenance medium was added to the infected control cultures. Cells infected with herpes simplex and polyoma viruses were harvested after incubation for 36 hr and 5 days respectively and frozen. In preparation for assay the cultures were frozen and thawed twice and centrifuged at 20o0 rev./min, for 15 min. to remove cellular debris. The supernatant fluids were stored at -7 °o until assayed.
Biochemical studies. Green monkey kidney ceils were grown at 37 ° in Falcon plastic bottles for 7 days in normal maintenance medium. The medium was decanted and replaced by either 5,6-dichloro-I-(2'-deoxy-fl-D-ribofuranosyl) benzimidazole (dDBZ) (0"5 re_M) dissolved in normal maintenance medium (6 ml.) or by normal maintenance medium alone. After ½ hr incubation at 37 °, either [3H]thymidine (o. I ml., 5 /AC, 0"25 #mole), [3H]uridine (o.I ml., 5 #¢, 0"25 #mole) or [14C]leucine (o-i ml., 1-25/zc, o'o4 #mole) was added. After 3o, 6o and 12o min. the fluid was decanted, cells were removed by scraping and decanted into ice cold trichloracetic acid (15 M, I-O ml.). The cells were washed repeatedly with trichloroacetic acid (IO %, 5 ml.) until 
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A. DIWAN AND OTHERS the supernatant fraction after centrifugation contained little or no radioactivity (i.e. counts were no greater than background activity).
The RNA fraction was prepared by dissolving in KOH (2 ml. 0"3 M) the fraction insoluble in cold perchloric acid and incubating it at 37 ° overnight. The incubated solution was cooled and acidified with 0"04 ml., 70% HC10~, and the precipitate removed by centrifugation. The radioactivity present in o-2 ml. was determined by counting in a liquid scintillation counter.
The DNA and protein fractions were prepared by dissolving the cold acid-insoluble precipitate in I.o ml. o'5 M KOH. The amount of radioactivity present in o.2 ml. was determined as above.
RESULTS

Cytotoxicity studies
5,6-Dichtoro-I-(2'-deoxy-~-o-ribofuranosyl)benzimidazole was the most toxic compound for both cell lines. 5,6-Dimethyl-I-(2'-deoxy-/?-o-ribofuranosyl)benzimidazole was toxic to both cell lines at a concentration of 2"5 mM. 5,6-Dimethyl-r-(2'-deoxy-~-o-ribofuranosyl)benzimidazole and 5,6-dichloro-I-(z'-/%D-ribofuranosyl)benzimidazole (dDBZ) were not observably toxic to either cell line at the maximum attainable solubility. It is noteworthy that the c~-configuration of the 5,6-dichloro derivative was more toxic than the corresponding compound in the t-configuration (Table I) . 
Table i. Cytotoxicity of certain substituted I-(2'-deoxy-D-ribofuranosyl)-
Antiviral activity
The dichloro derivative with the pentose in the co-configuration exerted a modest 2 9 % inhibition at the highest non-toxic concentration tested. The dimethyl-fl derivative was inhibitory for both viruses at a concentration of ~ raM; however, the dimethyl-~ derivative was four times as effective. The dichloro-/? derivative (dDBZ) was the most inhibitory compound for both herpes simplex and polyoma viruses (Table z) . Neither herpes simplex virus nor polyoma virus was inhibited when the host cells were pretreated with these compounds for 2 4 hr and the drug removed before infection. 
Studies with 5,6-dichloro-I-( z' deoxy-fl-D-ribofuranosyl)benzimidazole ( dD BZ)
This substance received additional study because of its marked antiviral potency. ExtraceUular herpes simplex virus incubated at 37 ° for 3 hr with or without dDBZ 
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was inactivated at the same rate, indicating that this compound did not have a direct inactivating effect on the intact virus particle. In the presence of dDBZ herpes simplex virus was synthesized after a considerable lag and was first detected 24 hr after infection (Fig. 2) . Virus grown in either the presence or absence of dDBZ reached maximal titres at 48 hr after which time the rate of inactivation exceeded the rate of new virus production. Marked inhibition in repeated experiments was obtained when dDBZ was added as late as 15 hr after infection. At the multiplicity of infection of 2 to 3 p.f.u, per cell used in these experiments, it is unlikely that inhibition observed after addition of dDBZ as late as 15 hr after infection represents inhibition of secondary cycles. More likely the late production of virus in cells initially infected is inhibited. Since the compound is active when added up to 15 hr after infection, the inhibition is not by prevention of viral penetration but rather is an intracellular event.
Unsuccessful attempts were made to prevent the inhibition by inclusion of the following compounds in the medium: deoxyguanosine, deoxycytidine, thymidine, adenine, and adenosine. Each compound was added in a concentration that was equimolar, tenfold in excess, and tenfold less than the inhibitory concentration of dDBZ.
Comparative antiviral studies with 5, 6, 5, 
benzimidazole (DRB) and 5,6-dichloro-I-(2'-deoxy-fl-D-ribofuranosyl) benzimidazole (dDBZ) using herpes simplex virus and polio virus
Tamm et al. (1954) showed that DRB inhibits both DNA and RNA viruses. A comparative study of the cytotoxicity and antiviral activity of 5,6-dichlorobenzimidazole, its ribonucleoside (DRB) and its deoxyribonucleoside (dDBZ) was made using a DNA virus, herpes simplex, and an RNA virus, polio virus. Several strains of poliovirus were used and these included the virulent wild Type I MAI-IONEY strain, virulent wild Type 2 MEF I strain and attenuated Type I LSC 12AB strain. The free base, 5,6-dichlorobenzimidazole, and dDBZ, the corresponding deoxyriboside in o.i mM concentration, were equally inhibitory for herpes simplex virus; Table 4 . however, 5,6-dichlorobenzimidazole, but not dDBZ, was cytotoxic to the host cells at a concentration of 0"25 mM. ORB and dDBZ were equally inhibitory at o'25 mu when the multiplicity of infection of herpes simplex virus was 2 to 3; however, ORB but not dDBZ was cytotoxic at this concentration. The cytotoxicity produced by ORB and 5,6-dichlorobenzimidazole became apparent after 48 hr incubation. Since 5,6-dichlorobenzimidazole and its ribonucleoside (ORB) were cytotoxic at a concentration of 0"25 mi for mouse kidney cells and polyoma virus has a longer growth cycle than the cell survival time, these compounds could not be used for studies of potential inhibition of polyoma virus. Although used at a concentration of 0"25 mM, dDBZ inhibited herpes simplex virus without observable cytotoxicity (Table 3) . Table 5 . Effect of 5, dDBZ was the least inhibitory compound for the IaEF I virus (Type 2) and the MAHONEY virus (Type I), and was not inhibitory for the LSC 1 2AB attenuated strain of poliovirus (Type I) (Table 4) . ORB inhibited all three strains of poliovirus and 5,6-dichlorobenzimidazole inhibited both the MEF I and the LSC 1 2AB strains, the only two strains tested with this drug. The absence of cytotoxicity of dDBZ was again most apparent.
Cytotoxicity and antiviral activity of certain substituted benzimidazoles against three strains of poliovirus
ConoBn
Effect of dDBZ on the synthesis of RNA, DNA and protein by uninfected green monkey kidney cells
dDBZ inhibited the synthesis of RNA, DNA and protein by green monkey kidney cells at the concentration required for inhibition of viral replication (Table 5 ). The inhibition of RNA was greater than that of either DNA or protein at the three periods of time studied. A comparison made between dDBZ and the free base, 5,6-dichlorobenzimidazole, of the inhibition of RNA synthesis in these cells indicated no significant difference.
DISCUSSION
The use of metabolic inhibitors has facilitated considerably the study of the biochemistry of viral reproduction. 5-Iodo-2'-deoxyuridine (IUdR, Idoxuridine), an analogue of thymidine, and adamantanamine have been used clinically for the treatment of herpes keratitis and selected types of influenza, respectively, in man. Recent advances in the chemotherapy of viral diseases have been reviewed (Prusoff, 1967) . dDBZ has been shown not to inhibit the LSC I strain of poliovirus, whereas the free base and its ribonucleoside (ORB) exert marked antiviral activity. However, dDBZ did exert antiviral activity against the MAHONE¥ (Type I) strain of poliovirus. Similarly, actinomycin D was shown by Reich et al. 0962 ) not to inhibit Type II poliovirus, whereas Shaffer & Gordon (~966) observed actinomycin D to inhibit attenuated LSC 12AB polio virus. Thus, the strain of virus and host cell are probably important in regard to the biological effect observed.
The inhibitory effect by dDBZ on the formation of RNA, DNA and protein in the uninfected cell indicates that the observed antiviral effects of this compound may be secondary to an effect on metabolic processes of th e host cell required for viral propagation. The more pronounced inhibition of the synthesis of RNA as compared to that of the formation of either DNA or protein and the similar magnitude of RNA inhibition produced by dDBZ and the free base, 5,6-dichlorobenzimidazole, is compatible with a cleavage of the nucleoside to the free base and subsequent inhibition of a key metabolic step either in this form or more probably at the nucleotide level. This possibility has not been explored further. An unexplained paradox is the failure of dDBZ to exert a cytotoxic effect at a molar concentration in which the free base (5,6-dichlorobenzimidazole) is cytotoxic. If dDBZ were cleaved before exerting its antiviral effect, then a cytotoxic effect should have been observed. The inability of dDBZ to exert any inhibitory effect on the growth of polio virus, LSC r 2AB (Type 0, indicates that either the antiviral activity of this compound is not secondary to an effect in the host cell, or the host cell reaction affected is not essential for the replication of all viruses.
